Pharma companies fined over £3m in CMA nortriptyline probe
King Pharmaceuticals, Auden Mckenzie, Lexon (UK) and Alissa Healthcare broke the law in relation to nortriptyline supply, according to the Competitions and Markets Authority (CMA).
King Pharmaceuticals, Auden Mckenzie, Lexon (UK) and Alissa Healthcare broke the law in relation to nortriptyline supply, according to the Competitions and Markets Authority (CMA).